The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 09, 2025

Filed:

Aug. 31, 2022
Applicants:

University of Virginia Patent Foundation, Charlottesville, VA (US);

Georgia Tech Research Corporation, Atlanta, GA (US);

Inventors:

Thomas H. Barker, Charlottesville, VA (US);

Leandro Moretti, Charlottesville, VA (US);

Lizhi Cao, Acton, MA (US);

John Nicosia, Atlanta, GA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/46 (2006.01); C07K 16/00 (2006.01); C07K 16/18 (2006.01); C40B 20/04 (2006.01); C40B 40/10 (2006.01); G01N 33/563 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); C40B 20/04 (2013.01); C40B 40/10 (2013.01); G01N 33/563 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2319/02 (2013.01); C07K 2319/21 (2013.01);
Abstract

Provided are antibodies that include amino acid sequences of SEQ ID NOs: 2, 4, and 6-12, or amino acid sequences that are about 95% identical thereto, and fragments thereof. Also provided are scFv peptides that include a Vsegment having a first amino acid sequence of amino acids 4-113 of any one of SEQ ID NOs: 2 and 8-12, a Vsegment having a second amino acid sequence having amino acids 113-237 of SEQ ID NOs. 2 and 8-12, or both; nucleic acids encoding the same; methods for using the same to detect and/or target conformational states of FN in samples; methods for treating diseases and/or disorders and/or for meliorating at least one symptom of consequence of a disease or disorder associated with abnormal expression of a force-induced conformational state of FN in subjects; and methods for screening for compounds having selective binding activities for conformational states of FN.


Find Patent Forward Citations

Loading…